Literature DB >> 1636231

Surgical techniques for endoscopic resection of bladder cancer.

M S Soloway1, J Patel.   

Abstract

Accompanying the advances in surgical techniques and new intravesical and systemic therapeutic agents for the treatment of individuals with bladder cancer has been the development of greatly improved instrumentation for viewing the interior of the urinary tract and removing neoplasms. Fiberoptic lenses can now be combined with a video system, which enables the urologist to examine the lower urinary tract, not only more easily but with greater magnification. Training is obviously accelerated with the use of video endoscopy. The system also provides the opportunity for documentation and transmittal of the operative findings using either still or motion photography. The endoscopic procedure should be carried out in an orderly fashion. Sufficient lenses and cautery loops must be available to visualize the entire lower urinary tract and to biopsy or resect any abnormality and ensure hemostasis. The urologist should work closely with the pathologist to obtain sufficient cytologic and pathologic material to be confident of the presence or absence of tumor.

Entities:  

Mesh:

Year:  1992        PMID: 1636231

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  5 in total

1.  Safety and efficacy of bipolar energy for transurethral resection of bladder tumours: a prospective quasi-randomized study.

Authors:  Vasudevan Thirugnanasambandam; Jeyaraman Ramanathan
Journal:  Turk J Urol       Date:  2017-05-03

Review 2.  Prognostic factors in superficial bladder cancer.

Authors:  D K Chopin; Z Popov; V Ravery; J Bellot; A Hoznek; J J Patard; C C Abbou; M Colombel
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

3.  Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy.

Authors:  M Lodde; R Mayr; T Martini; E Comploj; S Palermo; E Trenti; E Hanspeter; H M Fritsche; C Mian; A Pycha
Journal:  World J Urol       Date:  2012-11-10       Impact factor: 4.226

4.  The evaluation and follow-up of patients with Ta, Tcis, and T1 bladder cancer.

Authors:  M S Soloway
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

Review 5.  ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer.

Authors:  Leonardo L Monteiro; J Alfred Witjes; Piyush K Agarwal; Christopher B Anderson; Trinity J Bivalacqua; Bernard H Bochner; Joost L Boormans; Sam S Chang; Jose L Domínguez-Escrig; James M McKiernan; Colin Dinney; Guilherme Godoy; Girish S Kulkarni; Paramananthan Mariappan; Michael A O'Donnell; Cyrill A Rentsch; Jay B Shah; Eduardo Solsona; Robert S Svatek; Antoine G van der Heijden; F Johannes P van Valenberg; Wassim Kassouf
Journal:  World J Urol       Date:  2018-08-14       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.